Medical Data Vision Co.,Ltd.
3902メディカル・データ・ビジョン株式会社
Financials
Japan GAAP · consolidated · fiscal year to 2025-12-31- Revenue
- ¥6.5bn
- Net income
- ¥280m
- ROE
- 9.1%
- Equity ratio
- 64.4%
- Dividend / share
- —
- Employees
- 336
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | ¥6,539m | ¥280m | ¥4,778m | ¥3,111m | 9.1% | ¥7.4 | ¥782m |
| 2024-12-31 | ¥5,907m | −¥791m | ¥4,749m | ¥3,155m | — | ¥-20.73 | −¥878m |
| 2023-12-31 | ¥6,419m | ¥979m | ¥6,221m | ¥4,317m | 25.2% | ¥25.63 | ¥1,616m |
| 2022-12-31 | ¥6,105m | ¥871m | ¥4,897m | ¥3,606m | 24.2% | ¥22.77 | ¥911m |
| 2021-12-31 | ¥5,672m | ¥1,087m | ¥5,535m | ¥4,206m | 26.3% | ¥27.74 | ¥1,083m |
Indicators
Computed by us from filings · fiscal year to 2025-12-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 9.1 | 53.3 |
| Ordinary margin | 0.0552 | 41.3 |
| Equity ratio, % | 64.4 | 65.2 |
| Revenue growth | 0.107 | 71.2 |
| Net income growth | 1.3542 | 88.6 |
| Operating cash flow / assets | 0.1637 | 92.1 |
Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.
Via /v1/companies/3902/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/3902/voting/v1/companies/3902/tender-offersOwnership changes
All companies →- 2026-02-20
Goldman Sachs Japan Co.,Ltd. cut holdings in Medical Data Vision Co.,Ltd. (3902) to 0.18% from 5.62%, below the 5% threshold.
- 2026-02-19
Nomura Securities Co.,Ltd. cut holdings in Medical Data Vision Co.,Ltd. (3902) to 1.82% from 5.22%, below the 5% threshold.
- 2026-02-10
SBI Holdings, Inc. raised holdings in Medical Data Vision Co.,Ltd. (3902) to 86.41% from 36.24%.
- 2026-02-10
Holdings of SBI Holdings, Inc. in Medical Data Vision Co.,Ltd. (3902) moved above 50% (36.24% -> 86.41%).
- 2026-02-09
NIPPON LIFE INSURANCE COMPANY states it may make proposals to the management of Medical Data Vision Co.,Ltd. (3902) (first filing).
- 2026-02-09
NIPPON LIFE INSURANCE COMPANY raised holdings in Medical Data Vision Co.,Ltd. (3902) to 86.41% from 36.24%.
- 2026-02-09
Holdings of NIPPON LIFE INSURANCE COMPANY in Medical Data Vision Co.,Ltd. (3902) moved above 50% (36.24% -> 86.41%).
- 2026-02-06
MEDIPAL HOLDINGS CORPORATION cut holdings in Medical Data Vision Co.,Ltd. (3902) to 0.00% from 8.03%, below the 5% threshold.
- 2026-02-04
Nomura Securities Co.,Ltd. reduced holdings in Medical Data Vision Co.,Ltd. (3902) to 5.22% from 5.31%.
- 2026-01-22
Goldman Sachs Japan Co.,Ltd. disclosed a 5.62% stake in Medical Data Vision Co.,Ltd. (3902), crossing the 5% reporting threshold.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| 株式会社メディパルホールディングス | 2026-02-03 – 2026-02-03 | -3,212,600 | −8.03pt | — | — |
| 日本生命保険相互会社 | 2026-02-03 – 2026-02-03 | +20,082,496 | +50.17pt | ¥1,693 | ¥1,693–1,693 |
| SBIホールディングス株式会社 | 2021-12-24 – 2024-10-11 | +5,277,700 | +13.16pt | — | — |
| レオス・キャピタルワークス株式会社 | 2021-12-16 – 2022-01-24 | -880,400 | −2.19pt | ¥1,097 | ¥1,097–1,097 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/3902/trades.
5% filings
Large shareholding reports on 3902| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-02-20 | Goldman Sachs Japan Co.,Ltd. | 0.18% | −5.44pt | — |
| 2026-02-19 | Nomura Securities Co.,Ltd. | 1.82% | −3.40pt | — |
| 2026-02-10 | SBI Holdings, Inc. | 86.41% | +50.17pt | business alliance collateral pure investment |
| 2026-02-09 | NIPPON LIFE INSURANCE COMPANY | 86.41% | +50.17pt | may make proposals |
| 2026-02-06 | MEDIPAL HOLDINGS CORPORATION | 0.00% | −8.03pt | — |
| 2026-02-04 | Nomura Securities Co.,Ltd. | 5.22% | −0.09pt | — |
| 2026-01-22 | Goldman Sachs Japan Co.,Ltd. | 5.62% | — | — |
| 2026-01-21 | NOMURA INTERNATIONAL PLC | 5.31% | — | — |
| 2025-12-24 | MEDIPAL HOLDINGS CORPORATION | 8.03% | 0.00pt | strategic holding |
| 2025-12-22 | SBI Holdings, Inc. | 36.24% | +0.98pt | business alliance collateral pure investment |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- 1 issues
- Book value
- ¥75m
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 1
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| HOUSEI Inc. 5035 | ¥75m | 0.0% | no |
Held by: MEDIPAL HOLDINGS CORPORATION 7459
Purposes, all holdings and mutual flags via /v1/companies/3902/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2025-12-31| Shareholder | Shares | Ratio |
|---|---|---|
| SBIホールディングス株式会社 | 14,507,214 | 38.32% |
| 株式会社メディパルホールディングス | 3,212,600 | 8.48% |
| 日本マスタートラスト信託銀行株式会社（信託口） | 2,401,300 | 6.34% |
| 東海東京証券株式会社 | 1,379,600 | 3.64% |
| BNY GCM CLIENT ACCOUNT JPRD ACISG（FE-AC） | 1,153,048 | 3.04% |
| individual holder | 880,000 | 2.32% |
| THE BANK OF NEW YORK MELLON140040 | 802,200 | 2.11% |
| individual holder | 800,600 | 2.11% |
| individual holder | 737,919 | 1.94% |
| シミックホールディングス株式会社 | 610,000 | 1.61% |
Get this as JSON
GET /v1/companies/3902
GET /v1/companies/3902/financials
GET /v1/companies/3902/details
GET /v1/companies/3902/segments
GET /v1/companies/3902/voting
GET /v1/companies/3902/tender-offers
GET /v1/companies/3902/indicators
GET /v1/companies/3902/earnings-releases
GET /v1/events?ticker=3902
GET /v1/companies/3902/trades
GET /v1/companies/3902/cross-holdings
GET /v1/companies/3902/brief